HP and chronic atrophic gastritis: In particular, these projects have shown a high prevalence of severe chronic gastritis and atrophic gastritis in Hp-positive participants [27]; high prevalence of the high-risk incomplete cell type among participants with intestinal metaplasia (unpublished data); high rates of treatment success with optimal regimens among participants with good adherence to the regimen [36]; and relatively low reinfection rates [52].